Stay updated on Nivolumab for Stage IIB-IIC Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Locations section on the page was reorganized to list New Jersey, New York, and Pennsylvania as separate subsections, replacing the prior 'New Jersey Locations', 'New York Locations', and 'Pennsylvania Locations' headings. The HHS Vulnerability Disclosure link was removed from the footer and the page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-23T21:44:15.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Added an Outcome Measure: Number of Adverse Events and a new Last Update Posted (Estimated) field; removed the Incidence of adverse events and Last Update Posted fields.
    Difference
    0.4%
    Check dated 2025-12-02T16:27:28.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, replacing Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:18:08.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice from the page; the study details and eligibility information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:46:53.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    No substantive changes to the trial's endpoints, eligibility criteria, or locations; the update appears cosmetic (e.g., timestamp) and does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T20:40:53.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    Updated operating-status notice and version 3.2.0; removed version 3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:09:38.000Z thumbnail image

Stay in the know with updates to Nivolumab for Stage IIB-IIC Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page.